Skip to content

Vaccinex, Inc.

VCNX

CIK 0001205922

← back to feed
Revenue (TTM)
$408K
+5.4% YoY FY Apr 2025
Net Income (TTM)
−$20.17M
+8.0% YoY FY Apr 2025
EPS Diluted (TTM)
−$24.12
+79.7% YoY FY Apr 2025
Gross Margin
50.7%
FY Apr 2025
Operating Margin
-5,191.7%
FY Apr 2025
Net Margin
-4,944.1%
FY Apr 2025
Free Cash Flow (TTM)
−$22.13M
FY Apr 2025
Cash
$1.11M
FY Apr 2025
Total Debt
$25K
FY Apr 2025
Shares Outstanding
2.68M sh
FY Apr 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings